Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Avicanna Inc (AVCNF)

Avicanna Inc (AVCNF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0200 +2.94%
on 07/16/20
1.2400 -15.32%
on 07/29/20
-0.1600 (-13.22%)
since 07/02/20
3-Month
0.9654 +8.76%
on 06/12/20
1.4450 -27.34%
on 05/11/20
-0.2225 (-17.49%)
since 05/01/20

Most Recent Stories

More News
Avicanna announces the award of two Canadian government NSERC grants: 1) Cannabinoid-based pharmaceutical formulations for the treatment of COVID-19 in collaboration with the University of Toronto; and, 2) Evaluation of cannabinoids for reversing cannabis-based toxicosis in collaboration with the University of Guelph

In addition to a recent MITACS award, Dr. Christine Allen, a Professor at the University of Toronto, was awarded an NSERC Alliance grant for development of cannabinoid-based pharmaceutical formulations...

AVCN.TO : 1.50 (unch)
AVCNF : 1.0500 (-4.55%)
Avicanna Announces Participation in a Medical Cannabis Real-World Evidence (MC-RWE) Research Study Led by the University Health Network in Partnership with Medical Cannabis by Shoppers(TM) using its Rho Phyto(TM) Advanced Medical Cannabis Formulary of Products

The Rho Phyto portfolio contains a full formulary of products including oil drops, sublingual sprays, capsules, and topicals that have controlled dosing, enhanced absorption and stability studies supported...

AVCN.TO : 1.50 (unch)
AVCNF : 1.0500 (-4.55%)
Cannabis & CBD Biopharma Investor Presentations Now Available for On-Demand Viewing

NEW YORK , July 10, 2020 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the Cannabis & CBD Biopharma Virtual lnvestor Conference...

CALI : 0.0700 (unch)
AVCN.TO : 1.50 (unch)
CRDL.TO : 2.44 (+0.83%)
LABS.TO : 1.06 (+1.92%)
WLLW.TO : 0.68 (+17.24%)
CANSF : 0.5133 (+6.05%)
FNNZF : 0.0758 (-5.25%)
MCOA : 0.0018 (-5.26%)
AVCNF : 1.0500 (-4.55%)
CRTPF : 1.8495 (+2.18%)
MEDIF : 0.7870 (-0.38%)
Live Investor Conference & Webinar: Cannabis & CBD Biopharma Industry Companies Present July 9th

, /PRNewswire/ -- Virtual Investor Conferences today announced the agenda for the upcoming Cannabis & CBD Industry Virtual Investor Conference. Individual investors, institutional investors, advisors...

AVCNF : 1.0500 (-4.55%)
MCOA : 0.0018 (-5.26%)
Live Investor Conference & Webinar: Cannabis & CBD Biopharma Industry Companies Present July 9th

NEW YORK , July 7, 2020 /PRNewswire/ -- Virtual Investor Conferences today announced the agenda for the upcoming Cannabis & CBD Industry Virtual Investor Conference. Individual investors, institutional...

AVCNF : 1.0500 (-4.55%)
CANSF : 0.5133 (+6.05%)
CRTPF : 1.8495 (+2.18%)
MCOA : 0.0018 (-5.26%)
MEDIF : 0.7870 (-0.38%)
AVCN.TO : 1.50 (unch)
CRDL.TO : 2.44 (+0.83%)
LABS.TO : 1.06 (+1.92%)
WLLW.TO : 0.68 (+17.24%)
Avicanna Announces Co-development of a Cannabinoid-based Formulation for Treatment of COVID-19 related Lung Inflammation with Support from the Mitacs Accelerate Program

Avicanna further expands its existing research collaboration with Dr. Christine Allen's Research Group at the University of Toronto to include the development of a cannabinoid-based pharmaceutical for...

AVCN.TO : 1.50 (unch)
AVCNF : 1.0500 (-4.55%)
Avicanna to Host Virtual Symposium Titled "Medical Cannabis 2.0" on July 21st, 2020 in Partnership with Medical Cannabis By Shoppers(TM) in Anticipation of the Launch of its Rho Phyto(TM) Product Line

- - -The symposium will present the evolution of medical cannabis including the Avicanna-led advancements in R&D for novel cannabinoid delivery forms and formulations in addition to enhanced access for...

AVCN.TO : 1.50 (unch)
AVCNF : 1.0500 (-4.55%)
Avicanna Completes First Ever Export of Feminized Hemp Seeds For Cultivation Use to the United States and Closes the Initial Sale

Seven million CBG dominant feminized seeds have been successfully exported to the US from Colombia and an additional seventy-five million seeds remain in inventory for sale to international markets.

AVCN.TO : 1.50 (unch)
AVCNF : 1.0500 (-4.55%)
Avicanna Successfully Registers the First Group of its Pura Earth(TM) CBD-Based Derma-Cosmetic Product Line in the European Union in Preparation for its Commercialization

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/...

AVCN.TO : 1.50 (unch)
AVCNF : 1.0500 (-4.55%)
Avicanna Reports First Quarter 2020 Financial Results and Provides Corporate Update

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/...

AVCN.TO : 1.50 (unch)
AVCNF : 1.0500 (-4.55%)
Trade AVCNF with:

Key Turning Points

2nd Resistance Point 1.0500
1st Resistance Point 1.0500
Last Price 1.0500
1st Support Level 1.0500
2nd Support Level 1.0500

See More

52-Week High 3.5300
Fibonacci 61.8% 2.3802
Fibonacci 50% 2.0250
Fibonacci 38.2% 1.6698
Last Price 1.0500
52-Week Low 0.5200

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar